AbbVie’s I Know IBD Project Wins Bronze at PR Awards 2025 for Enhancing IBD Awareness
On November 30, 2023, AbbVie announced that its I Know IBD (I know Inflammatory Bowel Disease) project received the Bronze award at the PR Awards 2025, organized by the Japan Public Relations Association. This recognition highlights the project's dedicated efforts in enhancing social understanding of Inflammatory Bowel Disease (IBD), particularly two major conditions: ulcerative colitis and Crohn's disease, which can significantly impact patients’ daily lives with symptoms like diarrhea and abdominal pain.
The I Know IBD initiative, launched in May 2022, aims to address one of the "invisible walls" that IBD patients face, particularly the anxiety surrounding restroom access when going out. It seeks to improve public awareness and understanding of IBD within society as a whole. This initiative comes at a time where misconceptions and stigma often hinder individuals from living fully.
The PR Awards are judged based on four criteria: strategy and research, creativity, execution quality, and the impact of the initiative. AbbVie's I Know IBD project has been recognized for tackling the various unnoticed challenges faced by IBD patients, described as "invisible walls." Increasing awareness is crucial, as many patients may modify their activities due to anxiety regarding restroom availability.
Since its inception, the initiative has garnered support across various industries, including beauty salons, restaurants, pharmacies, and hotels. As of the end of November 2025, the project has involved 199 partner companies and 3,188 participating locations across all 47 prefectures in Japan, creating a robust support network for IBD patients nationwide.
Feedback from the community highlights the importance of access to restrooms when outside, with many patients expressing how reassuring it is to know they have welcoming places to turn to.
AbbVie considers this award both an honor and a motivation to further their outreach efforts. The initiative aims to boost recognition and understanding of IBD, contributing to an improved quality of life for patients facing various challenges daily. Through the I Know IBD project, AbbVie aspires to continue widening the circle of support and fostering a more inclusive society.
The PR Awards, organized by the Japan Public Relations Association, aim to improve the quality of communication techniques in Japan and foster greater understanding of public relations. The awards recognize outstanding examples of PR practices that create impactful communication with society, inviting entries from various organizations and companies engaged in public relations activities.
The primary goal of this project is to identify and address the "invisible walls" surrounding the unnoticed challenges faced by IBD patients, with the ultimate aim of enhancing societal understanding and recognition of IBD. It was officially launched on May 17, 2022, ahead of the IBD Awareness Day on May 19.
AbbVie’s mission is to create and deliver innovative pharmaceuticals that solve significant health issues, and to address challenging medical conditions for the future. The company is committed to enriching individual lives by focusing on key areas including immune disorders, cancer, neurological conditions, eye care, and aesthetics through its Allergan aesthetic portfolio. For more information about AbbVie, visit www.abbvie.com.
The I Know IBD initiative, launched in May 2022, aims to address one of the "invisible walls" that IBD patients face, particularly the anxiety surrounding restroom access when going out. It seeks to improve public awareness and understanding of IBD within society as a whole. This initiative comes at a time where misconceptions and stigma often hinder individuals from living fully.
The PR Awards are judged based on four criteria: strategy and research, creativity, execution quality, and the impact of the initiative. AbbVie's I Know IBD project has been recognized for tackling the various unnoticed challenges faced by IBD patients, described as "invisible walls." Increasing awareness is crucial, as many patients may modify their activities due to anxiety regarding restroom availability.
Since its inception, the initiative has garnered support across various industries, including beauty salons, restaurants, pharmacies, and hotels. As of the end of November 2025, the project has involved 199 partner companies and 3,188 participating locations across all 47 prefectures in Japan, creating a robust support network for IBD patients nationwide.
Feedback from the community highlights the importance of access to restrooms when outside, with many patients expressing how reassuring it is to know they have welcoming places to turn to.
AbbVie considers this award both an honor and a motivation to further their outreach efforts. The initiative aims to boost recognition and understanding of IBD, contributing to an improved quality of life for patients facing various challenges daily. Through the I Know IBD project, AbbVie aspires to continue widening the circle of support and fostering a more inclusive society.
About the PR Awards
The PR Awards, organized by the Japan Public Relations Association, aim to improve the quality of communication techniques in Japan and foster greater understanding of public relations. The awards recognize outstanding examples of PR practices that create impactful communication with society, inviting entries from various organizations and companies engaged in public relations activities.
About the I Know IBD Project
The primary goal of this project is to identify and address the "invisible walls" surrounding the unnoticed challenges faced by IBD patients, with the ultimate aim of enhancing societal understanding and recognition of IBD. It was officially launched on May 17, 2022, ahead of the IBD Awareness Day on May 19.
About AbbVie
AbbVie’s mission is to create and deliver innovative pharmaceuticals that solve significant health issues, and to address challenging medical conditions for the future. The company is committed to enriching individual lives by focusing on key areas including immune disorders, cancer, neurological conditions, eye care, and aesthetics through its Allergan aesthetic portfolio. For more information about AbbVie, visit www.abbvie.com.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.